The IFN score, STAT1, ADAR, CCL2, and CXCL10 levels were significantly elevated at both active and inactive SLE patient visits compared to HD (Figure 1A-E), establishing and confirming that these biomarkers were aberrantly overexpressed in our SLE patients. The gene discussed is CCL2; the disease is systemic lupus erythematosus.